The symptoms of gynecologic cancer chemotherapy vary greatly between patients and treatment cycles. It is critical to keep track of symptoms on a frequent basis in order to guide symptom treatment. The researchers examined data from 26 individuals with gynecologic malignancies who were taking chemotherapy and reported their symptoms on a daily basis. There were 1562 calls where patients reported symptoms. Sixty-one percent had at least one moderate to severe symptom, while 39 percent reported at least one severe symptom. The most prevalent complaints were weariness (47% of calls), discomfort (41% of calls), and difficulty sleeping (25% of calls). These symptoms frequently coexist. However, the patterns of symptom onset and duration varied between individuals, indicating that regular symptom evaluations might be a better strategy than focusing on certain time periods. The researchers came to a conclusion.

To know more: About the original article click here.